Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Epilepsy × Histocompatibility Testing × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 6 Pancreatic Neoplasms 4 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thymoma 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Medulloblastoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Epilepsy 1 Ependymoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Bone Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Sirolimus 4 Everolimus 3 Anticonvulsants 2 ziprasidone 1 perampanel 1 enzalutamide 1 clevidipine 1 brivaracetam 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Therapeutic Touch 1 Temozolomide 1 Surgical Procedures, Operative 1 Sulfasalazine 1 Spironolactone 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Registries 1 Radiotherapy 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00152659 2023-04-26

Developing Criteria for Cortical Resections

University of Chicago

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡